Launched on December 20, 2011, the VanEck Biotech ETF (BBH) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity market.

BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) is one of the 10 most shorted biotech stocks to buy according to hedge funds. On March 2, Wedbush analyst Laura Chico increased the firm’s price target on ...

Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL) is one of the 10 most shorted biotech stocks to buy according to hedge funds. On February 20, Bank of America Securities lowered the price target on ...

Apellis Pharmaceuticals Inc. (NASDAQ:APLS) is one of the 10 most shorted biotech stocks to buy according to hedge funds. On March 5, Anupam Rama from JPMorgan increased the price target on Apellis ...

Linnaeus Therapeutics closed a $4.48 million equity round and won up to $22 million from a federal health agency. The company is studying pathways that may influence aging and disease.

Celcuity develops targeted cancer therapies and diagnostics, leveraging proprietary technology and strategic licensing in oncology.

CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the 10 most shorted biotech stocks to buy according to hedge funds. On February 17, Morgan Stanley increased its price target on CRISPR Therapeutics AG ...

Ladenburg, Germany Tuesday, March 10, 2026, 13:00 Hrs [IST] ...

THE National Insurance Property Development Company Limited (NIPDEC) has come under scrutiny for possibly facilitating favouritism towards some big pharmaceutical companies, while smaller suppliers ...

There are plenty of choices in the Sector - Health category, but where should you start your research? Well, one fund that might be worth investigating is ProFunds Biotech Ultra Sector Investor (BIPIX ...

Indian benchmark equity indices remained under heavy pressure in mid-morning trade as investors turned cautious, before ...

Reported Consolidated quarterly numbers for SKYBIOTECH HEALTHCARE are: Net Sales at Rs 0.96 crore in December 2025 down 61.82% from Rs. 2.52 crore in December 2024. Quarterly Net ...